non-small cell lung cancer

Takeda’s ALUNBRIG gets FDA priority review for expanded indication in NSCLC
Pharmaceutical Business Review
Tue, 02/25/20 - 10:19 am
Takeda
Alunbrig
brigatinib
FDA
priority review
non-small cell lung cancer
FDA Grants Priority Review to Roche's Lung Cancer Drug Tecentriq
Motley Fool
Thu, 02/20/20 - 10:44 am
Roche
FDA
priority review
Tecentriq
non-squamous non-small cell lung cancer
non-small cell lung cancer
Novartis nabs priority review for a blockbuster-to-be aimed at NSCLC niche — delighting Incyte execs
Endpoints
Tue, 02/11/20 - 10:28 am
Incyte
Novartis
FDA
capmatinib
prioirty review
non-small cell lung cancer
Bristol-Myers Withdraws European Application for Lung Cancer Combo
Motley Fool
Sun, 02/2/20 - 11:51 pm
Bristol-Myers Squibb
Europe
Opdivo
Yervoy
non-small cell lung cancer
Racing Blueprint, Lilly drug gets priority review for RET hopeful
Fierce Biotech
Wed, 01/29/20 - 10:35 am
Eli Lilly
FDA
Blueprint Medicines
selpercatinib
LOXO-292
thyroid cancer
non-small cell lung cancer
BeiGene’s Tislelizumab Could Challenge Merck’s Keytruda in the Checkpoint Inhibitor Market
BioSpace
Thu, 01/23/20 - 12:22 pm
BeiGene
tiselizumab
non-small cell lung cancer
Merck
Keytruda
Spectrum Pharma Shares Slump After Lung-Cancer Drug Doesn't Meet Phase II Endpoint
TheStreet.com
Thu, 12/26/19 - 01:16 pm
Spectrum Pharma
lung cancer
clinical trials
poziotinib
non-small cell lung cancer
ESMO I-O: Roche silences Tecentriq doubters with latest lung cancer analysis
Fierce Pharma
Tue, 12/17/19 - 09:29 pm
ESMO
Roche
Tecentriq
non-small cell lung cancer
AZ’s Imfinzi approved in early lung cancer in China
Pharmaforum
Thu, 12/12/19 - 10:55 am
China
AstraZeneca
Imfinizi
non-small cell lung cancer
Merck's Keytruda lung cancer sales may face new pressure, but investors shouldn't sweat it: analyst
Fierce Pharma
Wed, 11/20/19 - 10:36 pm
Merck
Keytruda
non-small cell lung cancer
AstraZeneca, on BMS' heels, scores lung cancer win with Imfinzi combos
Fierce Pharma
Tue, 10/29/19 - 10:25 am
AstraZeneca
Imfinizi
non-small cell lung cancer
Bristol-Myers makes Opdivo pitch for frontline lung cancer with open label PhIII study
Endpoints
Tue, 10/22/19 - 10:39 am
Bristol-Myers Squibb
Opdivo
non-small cell lung cancer
advanced non-small cell lung cancer
clinical trials
Merck’s KEYTRUDA approved as monotherapy in China for first-line treatment of certain patients with advanced NSCLC
Pharmaceutical Business Review
Thu, 10/3/19 - 10:37 am
Merck
Keytruda
China
non-small cell lung cancer
Samsung Bioepis announces phase 3 results of SB8, Bevacizumab biosimilar candidate, at ESMO 2019 Congress
Pharmaceutical Business Review
Fri, 09/27/19 - 09:34 am
ESMO
Samsung Bioepis
clinical trials
SB8
biosimilars
bevacizumab
non-small cell lung cancer
OncoCyte Acquires Razor Genomics to Improve Management of Early-Stage Lung Cancer
BioSpace
Tue, 09/24/19 - 07:14 pm
OncoCyte
Razor Genomics
diagnostics
M&A
non-small cell lung cancer
Roche’s Tecentriq monotherapy significantly improves OS in phase III lung cancer study
Pharmaceutical Business Review
Thu, 09/12/19 - 10:17 am
Roche
Tecentriq
clinical trials
non-small cell lung cancer
Merck KGaA nabs FDA “Breakthrough” tag for MET-targeting lung cancer drug
Pharmaforum
Wed, 09/11/19 - 11:48 pm
FDA
Merck KGaA
MET
lung cancer
tepotinib
non-small cell lung cancer
WCLC: Merck's Keytruda dispels 'urban legend' with latest lung cancer survival win
Fierce Pharma
Tue, 09/10/19 - 09:30 am
Merck
Keytruda
non-small cell lung cancer
WCLC
Lilly's RET drug, nabbed in Loxo buyout, hits 68% ORR in lung cancer
Fierce Biotech
Mon, 09/9/19 - 10:21 am
Eli Lilly
Loxo Oncology
LOXO-292
non-small cell lung cancer
Novartis’ lung cancer drug edges closer to market after FDA grants fast review
Pharmaforum
Fri, 09/6/19 - 12:27 pm
Novartis
Incyte
FDA
breakthrough therapy
non-small cell lung cancer

Pages